European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

OxProtect GmbH, Münster, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

OxProtect GmbH

Identification

Ut
District Court of Münster HRB 7779
EUID
DER2713.HRB7779

Address

Mendelstr. 11, 48149 Münster, Germany

Corporate purpose

The company's purpose is the planning and development of diagnostic test procedures tested for clinical relevance and application-oriented research in the field of hemostaseology, inflammation and arteriosclerosis.

History

Network

Loading network

Publications

15 Jul 2025
Original document: “Liste der Gesellschafter“
15 Oct 2020 via Consejo Nacional DE Investigaciones Cientificas Y Tecnicas (Conicet)
EU funding (€9,200.00): Translational Research on Endometriosis
30 Sept 2020
Patent: Detection and Removal of Misfolded Proteins/Peptides
16 Apr 2018 in Fk
Public funding (€146,244): Development of biofunctional vascular implants with antithrombogenic coating, sub-projects: investigation and characterization of antithrombogenic coated biomimetic stents …
1 Dec 2017 in Hor
EU funding: Regulatory Science Framework for Nano(bio)material-based Medical Products and Devices
1 Sept 2016
Patent: Verwendung von Proteinen/Peptiden, welche an GRP78 (BIP) binden, in Labormethoden zum Monitoring von Thrombozyten-Aggregationshemmern
19 Jan 2016
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014
23 Jun 2015
Wordmark: “OxProtect“
2 Jun 2015
Patent: Unbeladene PEGylierte Liposomen zur Verwendung als Arzneimittel zur Prophylaxe und Therapie von hämorrhagischen und thrombo- embolischen Erkrankungen
1 May 2015 in Hor
EU funding: European Nanomedicine Characterization Laboratory
9 Jan 2015
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013
4 Feb 2014
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
22 Jan 2013
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
16 Aug 2012
Patent: Verwendung von Proteinen/Peptiden, welche an GRP78 (BIP) binden, in Labormethoden zum Monitoring von Thrombozyten-Aggregationshemmern
10 May 2012
Patent: Unbeladene PEGylierte Liposomen zur Verwendung als Arzneimittel zur Prophylaxe und Therapie von hämorrhagischen und thrombo- embolischen Erkrankungen
10 Feb 2012
Patent: USE of Proteins/Peptides That Bind to GRP78 (BIP), in Laboratory Methods for Monitoring Platelet Aggregation Inhibitors
10 Nov 2011
Patent: Plain Pegylated Liposomes for USE AS Medicinal Products for Prophylaxis and Therapy of Haemorrhagic and Thromboembolic Disorders
13 Oct 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
10 Feb 2011
Patent: Verwendung von Proteinen/Peptiden, welche an GRP78 (BIP) binden, in Labormethoden zum Monitoring von Thrombozyten-Aggregationshemmern
22 Dec 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
10 Nov 2010
Patent: Unbeladene PEGylierte Liposomen zur Verwendung als Arzneimittel zur Prophylaxe und Therapie von hämorrhagischen und thrombo- embolischen Erkrankungen
17 Dec 2009
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
13 Jan 2009
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007
11 Jan 2008
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006
27 Jul 2004
Reg­is­tra­tion · Managing Director: Martin Brodde · Capital: €25,000 · Seat: Münster · Legal form · Name: OxProtect GmbH · Proxy policy · Corporate Purpose
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "OxProtect GmbH, Münster, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.